CD8A and neoplasm: The higher density of CD8+ infiltration surrounding a tumor was associated with better response of advanced urothelial cancer treated with atezolizumub13,17 and suggested that the high load of detected immunogenic mutations may likely predict patients who would respond checkpoint blockage treatment54.